LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-8022 to CARDINAL HEALTH, INC. (CAGE 00E55) for the supply of LORATADINE TABLETS, identified by NSN 6505013770448 and NDC codes NDC51079-0246-20 and NDC00904-7511-61. The total contract value is $79.44 for four units delivered under line item CLIN 0001, with delivery due on July 14, 2026. Items must be shipped FOB destination to the USNS CARL BRASHEAR T-AKE 7 at FPO AP 96661, with all packages marked with the contract number SPE2DX-25-D-8022 and purchase order SPE2D9-26-F-7327, along with the specified NDC identifiers. Acceptance occurs at the delivery point by the Government, and payment is processed electronically through the Defense Finance and Accounting Service in Columbus, Ohio, using payment code SL4701 and accounting line BX: 97X4930 5CBX 001 2620 S33189. Cardinal Health is certified as both a Small Disadvantaged Business and a Women-Owned Small Business, triggering ongoing compliance requirements under federal small business programs. The order was issued through DLA Troop Support’s Medical Supply Chain office in Philadelphia with Lisa Quinn as the contracting officer, and delivery instructions align with DLAD PROC NOTE C19/C20 for freight handling. Packaging and labeling follow minimal explicit standards, with no specific MIL-STD requirements cited, though compliance with general DLA transportation protocols is implied. No formal evaluation factors, special contract requirements, or detailed inspection criteria beyond conformance to contract terms are documented, suggesting this is a streamlined, low-value procurement processed under a Lowest Price Technically Acceptable framework. The sole deliverable is pharmaceutical medication for onboard medical use by U.S. Navy personnel.